Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital

被引:9
|
作者
Zhang, Di [1 ]
Cui, Kai [2 ]
Wang, Taotao [1 ]
Shan, Yuanyuan [1 ]
Dong, Haiyan [1 ]
Feng, Weiyi [1 ]
Ma, Chen [1 ,3 ]
Dong, Yalin [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pharm, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Xian Univ Posts & Telecommun, Dept Management Econ, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China
来源
关键词
Pseudomonas aeruginosa; carbapenem resistantance; risk factors; mortality; ANTIMICROBIAL RESISTANCE; BACTEREMIA; ENTEROBACTERIACEAE; SELECTION;
D O I
10.3855/jidc.10150
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aimed to identify risk factors, especially antibiotic use and co-carriage with other bacteria for CRPA infection or colonization. Methodology: A retrospective study was conducted in the First Affiliated Hospital of Xi'an Jiaotong University, which involved a cohort of patients with Pseudomonas aeruginosa infection or colonization from January 2014 to June 2016. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA occurrence. Results: Eight hundred and eighty-eight patients were included in the study. More than 50% of the risk factors were associated with CRPA infection or colonization according to univariate analysis (P < 0.05), such as invasive procedures, co-carriage with Gram-negative pathogens, and prior treatment with some antibiotics. However, only prior exposure to carbapenems (OR: 8.005; CI: 4.507-14.217, P < 0.001), the days of carbapenems treatment (OR: 1.190; CI: 1.073-1.272; P < 0.001), and co-carriage with Escherichia coli (OR: 1.824; CI: 1.005-3.310, P = 0.048) were considered independent risk factors by multivariate analysis. A higher mortality was found among patients with CRPA infection or colonization (P < 0.05). Conclusions: Risk factors for CRPA infection or colonization were prior exposure to carbapenems, the days of carbapenems treatment, and co-carriage with Escherichia coli. The prevalence of CRPA could be influenced by Gram-negative pathogens, especially in Escherichia coli, and it need more researches. Moreover, restrictions in the clinical use of carbapenems should be taken into account.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [31] Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization
    Chen, Xia
    Zhou, Mao
    Yan, Qun
    Jian, Zijuan
    Liu, Wenen
    Li, Hongling
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [32] Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia, through a Six-Year Infection Control Program in a Hospital
    Papanikolopoulou, Amalia
    Gargalianos-Kakolyris, Panagiotis
    Stoupis, Athina
    Moussas, Nikos
    Pangalis, Anastasia
    Theodoridou, Kalliopi
    Chronopoulou, Genovefa
    Pantazis, Nikos
    Kantzanou, Maria
    Maltezou, Helena C.
    Tsakris, Athanasios
    MICROORGANISMS, 2023, 11 (05)
  • [33] Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa
    Gasink, Leanne B.
    Fishman, Neil O.
    Nachamkin, Irving
    Bilker, Warren B.
    Lautenbach, Ebbing
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (10): : 1175 - 1180
  • [34] Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit
    Kohlenberg, A.
    Weitzel-Kage, D.
    van der Linden, P.
    Sohr, D.
    Voegeler, S.
    Kola, A.
    Halle, E.
    Rueden, H.
    Weist, K.
    JOURNAL OF HOSPITAL INFECTION, 2010, 74 (04) : 350 - 357
  • [35] Non-carbapenem-producing carbapenem-resistant Pseudomonas aeruginosa in children: Risk factors, molecular epidemiology, and resistance mechanism
    Yin, Lijun
    Lu, Lu
    He, Leiyan
    Yan, Gangfeng
    Lu, Guoping
    Zhai, Xiaowen
    Wang, Chuanqing
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2025, 18 (02)
  • [36] An analysis of risk factors for carbapenem-resistant Enterobacteriaceae infection
    Gao, Yan
    Chen, Meilian
    Cai, Meng
    Liu, Kun
    Wang, Yimin
    Zhou, Chunlian
    Chang, Zhigang
    Zou, Qi
    Xiao, Shirou
    Cao, Yang
    Wang, Weihua
    Liu, Zhuang
    Lv, Linfang
    Luo, Yajun
    Wu, Yinghong
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 191 - 198
  • [37] An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward
    Peña, C
    Dominguez, MA
    Pujol, M
    Verdaguer, R
    Gudiol, F
    Ariza, J
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (09) : 938 - 943
  • [38] Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?
    Garvey, M. I.
    Bradley, C. W.
    Biggs, M. J.
    Holden, E.
    Gill, M. J.
    JOURNAL OF HOSPITAL INFECTION, 2018, 98 (03) : 238 - 240
  • [39] Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study
    Terahara, Fumitaka
    Nishiura, Hiroshi
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (10) : 4711 - 4722
  • [40] The epidemiology and virulence of carbapenem-resistant Pseudomonas aeruginosa in China
    Zhu, Ying
    Jia, Peiyao
    Yu, Wei
    Chu, Xiaobing
    Liu, Xiaoyu
    Yang, Qiwen
    LANCET MICROBE, 2023, 4 (09): : E665 - E665